COH

Cochlear

Health Care Equipment & Services

Cochlear is a leading global provider of implantable hearing solutions, known for its innovative cochlear implant systems. The company holds a strong market position due to its advanced technology and commitment to improving hearing outcomes. Cochlear's unique value lies in its continuous investment in research and development, ensuring cutting-edge solutions for hearing loss.

Cochlear

Health Care

Implants

Hearing

Shorted

short percentage3.89%

reported shorts2.5M

shares on issue65.398M

Shorted

short percentage

reported short positions

total shares on issue

About

website

cochlear.com

industry

Health Care Equipment & Services

address

1 University Avenue, MACQUARIE UNIVERSITY, NSW, AUSTRALIA, 2109

Connect

Key Metrics

market cap

$17.27B

p/e ratio44.37

eps$5.95

dividend yield161.00%

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

View all stocks in this industry

Short Position Trends

Track bearish sentiment and short interest over time

Historical Price Data

View stock price movements, volume, and trading patterns

Industry & Focus

Cochlear

Health Care

Implants

Hearing

ASX

Company Overview

AI-generated company summary

Company History

Cochlear was founded in 1981, following the pioneering work of Dr. Graeme Clark in developing the first multi-channel cochlear implant. Over the years, the company has expanded its product offerings and global presence, becoming a leader in implantable hearing solutions. Major milestones include the launch of the Nucleus® cochlear implant system and the development of the world's first smart cochlear implant system.

Competitive Advantages

Cochlear's competitive advantages include its strong brand reputation, extensive global distribution network, and continuous innovation in hearing technology. The company's focus on research and development ensures it remains at the forefront of the industry.

Risk Factors

•Regulatory changes affecting medical devices
•Competition from other hearing solution providers
•Potential product recalls or failures

Recent Developments

Last 6 months

Cochlear has recently focused on expanding its product line with the introduction of the Nucleus® Kanso® 3 Sound Processor, enhancing connectivity and user experience.

Key People

Leadership team at Cochlear

Dig Howitt

CEO

Dig Howitt has been the CEO of Cochlear since 2018, leading the company with a focus on innovation and global expansion.

Stuart Sayers

CFO

Stuart Sayers joined Cochlear as CFO, bringing extensive experience in financial management and strategic planning.